Klaviyo, Inc. Form 8-K Summary
Business Context and Reporting Period
This Current Report on Form 8-K was filed by Klaviyo, Inc. on May 13, 2025, with the earliest event reported on May 14, 2025. The filing details a material definitive agreement involving a secondary offering of the Company's Series A common stock by its Chief Executive Officer and co-founder, Andrew Bialecki.
Key Financial Metrics and Transaction Details
- Transaction Type: Secondary offering of shares by a selling stockholder (CEO Andrew Bialecki).
- Shares Sold: 10,969,078 shares of Series A common stock.
- Offering Price: $32.8950 per share.
- Company Proceeds: $0. The Company did not receive any proceeds from this sale.
- Use of Proceeds: All net proceeds received by Mr. Bialecki were used to satisfy taxes incurred from the exercise of stock options.
- Option Exercises: In connection with the offering, Mr. Bialecki exercised options to purchase 21,429,184 shares of Series B common stock, converting 10,969,078 of these to Series A for the sale.
- Closing Date: May 16, 2025.
Note: This filing does not provide standard financial metrics such as revenue, profit, cash flow, margins, debt, or liquidity for the Company.
Material Changes and Unusual Items
The primary material event is the significant sale of shares by the CEO. This transaction was executed under an underwriting agreement with Goldman Sachs & Co. LLC and Morgan Stanley & Co. LLC. The filing notes that Mr. Bialecki plans to adopt a prearranged stock trading plan (Rule 10b5-1) following the closing of the offering.
Guidance, Outlook, and Risks
The filing does not contain updated financial guidance, forward-looking outlook statements, or specific risk factors beyond the standard representations and warranties in the Underwriting Agreement. The document references press releases issued on May 13 and May 14, 2025, regarding the offering launch, pricing, and the adoption of the stock trading plan.
Key Facts for Investor Verification
- Verify that the Company received no capital from this transaction, as it was a secondary sale by the CEO.
- Confirm the total number of shares sold (10,969,078) and the price per share ($32.8950) to assess market valuation at the time of the transaction.
- Review the attached Underwriting Agreement (Exhibit 1.1) for specific indemnification obligations and covenants.
- Monitor the implementation of the Rule 10b5-1 trading plan by the CEO as announced in the press releases.
- Check subsequent filings for any impact on the Company's capital structure or insider ownership percentages.